Natural polymeric nanoparticles as a non-invasive probe for mesenchymal stem cell labelling
Open Access
- 1 January 2020
- journal article
- research article
- Published by Taylor & Francis in Artificial Cells, Nanomedicine, and Biotechnology
- Vol. 48 (1), 770-776
- https://doi.org/10.1080/21691401.2020.1748641
Abstract
Non-invasive tracking of stem cells after transplant is necessary for cell therapy and tissue engineering field. Herein, we introduce natural and biodegradable nanoparticle to develop a highly efficient nanoprobe with the ability to penetrate the stem cell for tracking. Based on the use of (Gd3+) to label stem cells for magnetic resonance imaging (MRI) we synthesized nanoparticle-containing Gd3+. Gd3+ could be used as t(1)-weighted MRI contrast agents. In this study, chitosan-alginate nanoparticles were synthesized as a clinical Dotarem(R) carrier for decreased t(1)-weighted. Scanning electron microscopy (SEM), transmission electron microscopy (TEM), dynamic light scattering (DLS), and Fourier-transform infrared spectroscopy (FTIR) were utilized for nanoprobe characterization and ICP analysis was performed for Gd3+ concentration measurement. The results illustrate that nanoprobes with spherical shape and with a size of 80 nm without any aggregation were obtained. Relaxivity results suggest that r(1) in the phantom was 12.8 mM(-1)s(-1) per Gd3+ ion, which is 3.5 times larger than that for Dotarem(R) (r(1) similar to 3.6 mM(-1)s(-1) per Gd3+ ion) and this result for synthesized nanoprobe in stem cells 3.56 mM(-1)s(-1) per Gd3+ ion with 2.16 times larger than that for Dotarem(R) was reported and also enhanced signal in in-vivo imaging was observed. Chitosan-alginate nanoparticles as a novel biocompatible probe for stem cell tracking can be utilized in tissue engineering approach.Keywords
Funding Information
- Iran University of Medical Science (IR. IUMS. REC 1397.189)
This publication has 21 references indexed in Scilit:
- Mesenchymal stem cell-based gene therapy: A promising therapeutic strategyArtificial Cells, Nanomedicine, and Biotechnology, 2015
- Non-invasive In-Vivo Imaging of Stem Cells after Transplantation in Cardiovascular TissueTheranostics, 2013
- Superparamagnetic Iron Oxide Nanoparticles as MRI contrast agents for Non-invasive Stem Cell Labeling and TrackingTheranostics, 2013
- Mesenchymal stem cells for cartilage repair in osteoarthritisStem Cell Research & Therapy, 2012
- Long-TermIn VivoMagnetic Resonance Imaging Tracking of Endothelial Progenitor Cells Transplanted in Rat Ischemic Limbs and Their Angiogenic PotentialTissue Engineering, Part A, 2011
- Novel approaches for immune reconstitution and adaptive immune modeling with human pluripotent stem cellsBMC Medicine, 2011
- Tracking Stem Cells in the Cardiovascular SystemTrends in Cardiovascular Medicine, 2005
- Targeted contrast agents for magnetic resonance imaging and ultrasoundCurrent Opinion in Biotechnology, 2005
- Ex vivo cell labeling with 64 Cu–pyruvaldehyde-bis( N 4 -methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomographyProceedings of the National Academy of Sciences, 2002
- Bioluminescence imaging of lymphocyte trafficking in vivoExperimental Hematology, 2001